An Out-of-Specification (OOS) result is a test result that falls outside the established acceptance criteria. FDA's governing guidance — "Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production, Revision 1, May 2022" — updates the original 2006 guidance most articles still cite exclusively, and it's worth citing the current revision specifically.
The two-phase structure
Phase 1: Laboratory investigation
Phase 1 checks whether the OOS result was caused by a genuine laboratory error — an analyst mistake, an instrument malfunction, a calculation error — rather than a real manufacturing problem. Per FDA's guidance, Phase 1 should complete within 3–10 business days.
Phase 2: Manufacturing investigation
Phase 2 is only triggered if Phase 1 finds no laboratory error — meaning the result may reflect a genuine manufacturing or process issue. This is a critical branching point: Phase 2 isn't automatic, but skipping it when Phase 1 is inconclusive (rather than clearly attributing the result to lab error) is a common, citable shortcut.
The total timeline benchmark
Per FDA's Revision 1 (2022) guidance, the total investigation — both phases combined — should complete within 45 days maximum.
Why the linear framing is misleading
Most OOS content presents the process as one continuous investigation. In reality, it's two structurally distinct, gated stages: Phase 1 is a laboratory-focused inquiry with a narrower scope and faster timeline; Phase 2, when triggered, is a broader manufacturing investigation potentially involving process review, equipment history, and material batch records. Treating them as one undifferentiated "investigation" blurs exactly the branching logic FDA's guidance is built around.
What a defensible OOS record needs
- A documented root-cause conclusion for Phase 1 — not just "no lab error found" without supporting evidence.
- A clear decision point: does the result trigger Phase 2, and why?
- Timeline tracking against the 3-10 day (Phase 1) and 45-day (total) benchmarks.
- Linkage to a CAPA if the investigation identifies a systemic cause.
Ready to see this in your own lab? Book a free ValiCore demo.